530 related articles for article (PubMed ID: 26676341)
1. Inhibition of sphingosine kinase 1 ameliorates acute liver failure by reducing high-mobility group box 1 cytoplasmic translocation in liver cells.
Lei YC; Yang LL; Li W; Luo P; Zheng PF
World J Gastroenterol; 2015 Dec; 21(46):13055-63. PubMed ID: 26676341
[TBL] [Abstract][Full Text] [Related]
2. Sphingosine kinase 1 dependent protein kinase C-δ activation plays an important role in acute liver failure in mice.
Lei YC; Yang LL; Li W; Luo P
World J Gastroenterol; 2015 Dec; 21(48):13438-46. PubMed ID: 26730154
[TBL] [Abstract][Full Text] [Related]
3. C5a/C5aR pathway is essential for up-regulating SphK1 expression through p38-MAPK activation in acute liver failure.
Lei YC; Lu CL; Chen L; Ge K; Yang LL; Li W; Wu YH
World J Gastroenterol; 2016 Dec; 22(46):10148-10157. PubMed ID: 28028363
[TBL] [Abstract][Full Text] [Related]
4. [Association between protective effect of Liuwei Wuling tablets against acute liver injury and its inhibitory effect on cytoplasmic translocation of high-mobility group box-1 in hepatocytes in mice].
Lei Y; Li W; Luo P
Zhonghua Gan Zang Bing Za Zhi; 2016 Feb; 24(2):114-8. PubMed ID: 26983478
[TBL] [Abstract][Full Text] [Related]
5. Improved prescription of taohechengqi-tang alleviates D-galactosamine acute liver failure in rats.
Zhang Y; Luo JX; Hu XY; Yang F; Zhong S; Lin W
World J Gastroenterol; 2016 Feb; 22(8):2558-65. PubMed ID: 26937143
[TBL] [Abstract][Full Text] [Related]
6. The role of intracellular high-mobility group box 1 in the early activation of Kupffer cells and the development of Con A-induced acute liver failure.
Yang Q; Liu Y; Shi Y; Zheng M; He J; Chen Z
Immunobiology; 2013 Oct; 218(10):1284-92. PubMed ID: 23706499
[TBL] [Abstract][Full Text] [Related]
7. Sphingosine kinase 1 inhibition improves lipopolysaccharide/D-galactosamine-induced acute liver failure by inhibiting mitogen-activated protein kinases pathway.
Tian T; Tian W; Yang F; Zhao R; Huang Q; Zhao Y
United European Gastroenterol J; 2016 Oct; 4(5):677-685. PubMed ID: 27733910
[TBL] [Abstract][Full Text] [Related]
8. Liuweiwuling tablets attenuate acetaminophen-induced acute liver injury and promote liver regeneration in mice.
Lei YC; Li W; Luo P
World J Gastroenterol; 2015 Jul; 21(26):8089-95. PubMed ID: 26185380
[TBL] [Abstract][Full Text] [Related]
9. Dihydromyricetin alleviates carbon tetrachloride-induced acute liver injury via JNK-dependent mechanism in mice.
Xie J; Liu J; Chen TM; Lan Q; Zhang QY; Liu B; Dai D; Zhang WD; Hu LP; Zhu RZ
World J Gastroenterol; 2015 May; 21(18):5473-81. PubMed ID: 25987769
[TBL] [Abstract][Full Text] [Related]
10. Sphingosine kinase 1 regulates HMGB1 translocation by directly interacting with calcium/calmodulin protein kinase II-δ in sepsis-associated liver injury.
Tian T; Yao D; Zheng L; Zhou Z; Duan Y; Liu B; Wang P; Li Y
Cell Death Dis; 2020 Dec; 11(12):1037. PubMed ID: 33281190
[TBL] [Abstract][Full Text] [Related]
11. Endotoxin tolerance alleviates experimental acute liver failure via inhibition of high mobility group box 1.
Yang NB; Ni SL; Li SS; Zhang SN; Hu DP; Lu MQ
Int J Clin Exp Pathol; 2015; 8(8):9062-71. PubMed ID: 26464648
[TBL] [Abstract][Full Text] [Related]
12. Interleukin 17A plays a role in lipopolysaccharide/D-galactosamine-induced fulminant hepatic injury in mice.
Furuya S; Kono H; Hara M; Hirayama K; Sun C; Fujii H
J Surg Res; 2015 Dec; 199(2):487-93. PubMed ID: 26141869
[TBL] [Abstract][Full Text] [Related]
13. Synergistic effects of antibodies against high-mobility group box 1 and tumor necrosis factor-α antibodies on D-(+)-galactosamine hydrochloride/lipopolysaccharide-induced acute liver failure.
Wang W; Sun L; Deng Y; Tang J
FEBS J; 2013 Mar; 280(6):1409-19. PubMed ID: 23331758
[TBL] [Abstract][Full Text] [Related]
14. Sodium butyrate protects against toxin-induced acute liver failure in rats.
Yang F; Wang LK; Li X; Wang LW; Han XQ; Gong ZJ
Hepatobiliary Pancreat Dis Int; 2014 Jun; 13(3):309-15. PubMed ID: 24919615
[TBL] [Abstract][Full Text] [Related]
15. The therapeutic effect of CORM-3 on acute liver failure induced by lipopolysaccharide/D-galactosamine in mice.
Yan BZ; Yang BS; Li H; Zhang YF; Pei FH; Zhu AC; Wang XR; Liu BR
Hepatobiliary Pancreat Dis Int; 2016 Feb; 15(1):73-80. PubMed ID: 26818546
[TBL] [Abstract][Full Text] [Related]
16. Pretreatment of lipopolysaccharide (LPS) ameliorates D-GalN/LPS induced acute liver failure through TLR4 signaling pathway.
Zhang S; Yang N; Ni S; Li W; Xu L; Dong P; Lu M
Int J Clin Exp Pathol; 2014; 7(10):6626-34. PubMed ID: 25400741
[TBL] [Abstract][Full Text] [Related]
17. Gensenoside Rg1 protects against lipopolysaccharide- and d-galactose-induced acute liver failure via suppressing HMGB1-mediated TLR4-NF-κB pathway.
Jin H; Jiang Y; Lv W; Chen L; Zheng Y; Lin Y
Mol Cell Probes; 2021 Apr; 56():101706. PubMed ID: 33617946
[TBL] [Abstract][Full Text] [Related]
18. [Protective effect of glycogen synthase kinase 3β inhibition via peroxisome proliferator-activated receptor alpha activation in mice with acute liver failure].
Shi HB; Shi HL; Zhang XY; Chen DX; Duan ZP; Ren F
Zhonghua Gan Zang Bing Za Zhi; 2017 Mar; 25(3):211-216. PubMed ID: 28482409
[No Abstract] [Full Text] [Related]
19. Hepatoprotective effect of α-mangostin against lipopolysaccharide/d-galactosamine-induced acute liver failure in mice.
Fu T; Li H; Zhao Y; Cai E; Zhu H; Li P; Liu J
Biomed Pharmacother; 2018 Oct; 106():896-901. PubMed ID: 30119260
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the effects of the pretreatment and treatment with RhIL-11 on acute liver failure induced by D-galactosamine.
Nie XH; Han T; Ha FU; Liang N; Wang SH; Zhu ZY; Xiang HL
Eur Rev Med Pharmacol Sci; 2014; 18(8):1142-50. PubMed ID: 24817287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
